Eric Patzer serves as Executive at Aridis Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Eric Patzer has executed 4 insider transactions totaling $75.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 24, 2024 involved purchasing 714,286 shares valued at $50.0K.
Eric Patzer currently holds 884,600 shares of Aridis Pharmaceuticals, Inc. (ARDS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eric Patzer has been a net buyer of ARDS stock. They have purchased $75.0K and sold $0 worth of shares.
Eric Patzer's most recent insider trade was on Jun 24, 2024, when they purchased 714,286 shares at $0.07 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 27, 2021 | ARDS | $25.0K | Purchase | 5,175 | $4.84 | Discretionary |
| Dec 22, 2020 | ARDS | $0 | Gift | 16,000 | $N/A | Discretionary |